363.40
+7.25(+2.04%)
Currency In INR
| Previous Close | 356.15 |
| Open | 357.95 |
| Day High | 364.95 |
| Day Low | 356.7 |
| 52-Week High | 406 |
| 52-Week Low | 291 |
| Volume | 2.28M |
| Average Volume | 2.94M |
| Market Cap | 486.18B |
| PE | 113.49 |
| EPS | 3.21 |
| Moving Average 50 Days | 356.13 |
| Moving Average 200 Days | 351.62 |
| Change | 8.15 |
If you invested ₹1000 in Biocon Limited (BIOCON.NS) 10 years ago, it would be worth ₹4,890.98 as of October 20, 2025 at a share price of ₹363.4. Whereas If you bought ₹1000 worth of Biocon Limited (BIOCON.NS) shares 5 years ago, it would be worth ₹833.58 as of October 20, 2025 at a share price of ₹363.4.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States
GlobeNewswire Inc.
Jul 15, 2025 7:25 PM GMT
BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today annou